CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
The TETRIS project focuses on improving radiation protection in breast cancer treatment by developing personalized risk scores for patients. It aims to integrate patient-specific data with radiation dose information to minimize side effects and explore the use of digital twins for enhanced risk assessment.
Radiation protection and safety measures are essential to ensure adequate quality & safety in radiotherapy (RT).
Side effects are systematically mitigated through optimisation and individualisation.Breast cancer (Bca) is the most common cancer in women in Europe, leading to millions of BCa survivors in Europe; this group is projected to increase in the next decades.
Randomised trials established the role of RT following breast surgery.
Careful RT planning and delivery allow targeting the breast…
FONDAZIONE IRCCS ISTITUTO NAZIONALE DEI TUMORI
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Sweden, Stockholm
Type: Public body
Activity type: Public bodies (excluding Research Organisations and Secondary or Higher Education Establishments)
SME: No
FUNDACION PRIVADA INSTITUTO DEINVESTIGACION ONCOLOGICA DE VALL-HE
Spain, Barcelona
Type: Research institute
Activity type: Research Organisations
SME: No
France, Loos
Type: SME
Activity type: Private for-profit entities (excluding Higher or Secondary Education Establishments)
SME: Yes
France, ENTZHEIM
Type: SME
Activity type: Private for-profit entities (excluding Higher or Secondary Education Establishments)
SME: Yes
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
Guests see up to 5 keywords.